Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Petros Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues6.07.89.615.6
            Revenue growth-23.3%-18.3%-38.6% 
Cost of goods sold2.31.64.07.4
Gross profit3.76.25.58.2
            Gross margin61.8%79.5%57.7%52.3%
Selling, general and administrative12.215.615.719.7
Research and development1.71.80.5 
EBITA-6.9-11.2-17.3-16.9
            EBITA margin-114.6%-143.1%-180.8%-108.3%
Amortization of intangibles5.66.9  
EBIT-12.5-18.0-17.3-16.9
            EBIT margin-207.9%-231.1%-180.8%-108.3%
Pre-tax income-20.0-9.0-22.0-33.2
Income taxes0.00.0-1.4-0.6
            Tax rate0.0%0.0%6.5%1.9%
Net income-20.0-9.0-20.6-32.5
            Net margin-334.4%-115.0%-215.3%-208.7%
 
Diluted EPS($9.68)($8.25)($3.85)($13.22)
Shares outstanding (diluted)2.11.15.32.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy